EUVIMEDEUVIMED entdecken
Crossref

Serum neopterin and orexin-A levels in different stages of diabetic retinopathy

Abdurrahman Alpaslan Alkan iD, Burak Arslan iD, Delil Özcan iD, Kemal Tekin iD

Clinical and Experimental Optometry · 2025

DOI: 10.1080/08164622.2024.2374875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Optometry, 2025. Verfasst von Abdurrahman Alpaslan Alkan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, İstanbul Cerrahi Hospital, İstanbul, Turkey. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Orexins, Neopterin. Die Arbeit nennt 49 Literaturangaben. Gefördert von: The study did not receive any funding, public, commercial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CLINICAL RELEVANCE: Retinopathy is one of the most common microvascular complications of diabetes mellitus and is the leading cause of vision loss in the working middle-aged population. BACKGROUND: This study aimed to investigate the value of neopterin and orexin-A levels in patients with diabetes mellitus with different stages of diabetic retinopathy and without diabetic retinopathy and to compare those findings with results from healthy individuals without diabetes mellitus. METHODS: In total, 65 patients with type 2 diabetes mellitus and 22 healthy individuals without diabetes mellitus were enrolled in this prospective study. The participants were separated into four subgroups. The first subgroup included 25 patients without diabetic retinopathy, the second subgroup included 20 patients non-proliferative diabetic retinopathy, the third subgroup included 20 patients with proliferative diabetic retinopathy, and the fourth subgroup included 22 healthy individuals without diabetes mellitus as controls. Serum neopterin and orexin-A levels were analysed and compared among the groups. RESULTS: The age and gender of the participants between the four subgroups were not statistically significantly different (p > 0.05). The mean neopterin levels were significantly higher in patients included in the diabetes mellitus subgroups compared with the controls (p 0.05). CONCLUSION: Patients with diabetes mellitus have higher serum neopterin and lower serum orexin-A levels compared with healthy individuals without diabetes mellitus. Moreover, serum neopterin levels increase with progression of diabetic retinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyOrexinsNeopterinHumansMaleFemaleMiddle AgedProspective StudiesBiomarkersDiabetes Mellitus, Type 2AdultDisease Progression

Stichwörter der Autor:innen

Diabetes mellitusdiabetic retinopathyneopterinorexin-Aserum biomarker

Substanzen

OrexinsBiomarkersNeopterin

Autor:innen und Institutionen

  • Ophthalmology Department, İstanbul Cerrahi Hospital, İstanbul, Turkey.
  • Department of Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Ophthalmology Department, Seyrantepe Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
  • Ophthalmology Department, Ulucanlar Eye Training and Research Hospital, Ankara, Turkey.

ORCID-Profile: Abdurrahman Alpaslan Alkan, Burak Arslan, Delil Özcan, Kemal Tekin

Förderung

  • The study did not receive any funding
  • public, commercial

Zitieren

APA

Alkan, A. A., Arslan, B., Özcan, D., & Tekin, K. (2025). Serum neopterin and orexin-A levels in different stages of diabetic retinopathy. Clinical and Experimental Optometry. https://doi.org/10.1080/08164622.2024.2374875

Vancouver

Alkan AA, Arslan B, Özcan D, Tekin K. Serum neopterin and orexin-A levels in different stages of diabetic retinopathy. Clinical and Experimental Optometry. 2025. doi:10.1080/08164622.2024.2374875

BibTeX
@article{Alkan2025,
  author = {Alkan, Abdurrahman Alpaslan and Arslan, Burak and Özcan, Delil and Tekin, Kemal},
  title = {Serum neopterin and orexin-A levels in different stages of diabetic retinopathy},
  journal = {Clinical and Experimental Optometry},
  year = {2025},
  doi = {10.1080/08164622.2024.2374875}
}
Kostenlos starten →